Humerus fracture

disease
On this page

Also known as fracture, humeralfractures, humeralhumeral fracture

Summary

Humerus fracture (MONDO:0005319) is a disease with 5 GWAS associations across 7 studies and 55 clinical trials. Top therapeutic interventions include teriparatide. A subtype of bone fracture — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • GWAS associations: 5
  • Clinical trials: 55

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namehumerus fracture
Mondo IDMONDO:0005319
EFOEFO:0003943
MeSHD006810
SNOMED CT66308002
Anatomy (UBERON)UBERON:0000976
Is cancer (heuristic)no

Also known as: fracture, humeral · fractures, humeral · humeral fracture

Data availability: 5 GWAS associations (7 studies).

Disease family

This is a subtype of bone fracture. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: injurybone fracturehumerus fracture

Related subtypes (6): spinal fracture, tibia fracture, ulna fracture, radius fracture, hip fracture, jaw fracture

Genetics & variants

GWAS landscape

5 GWAS associations across 7 studies. Top hits map to 4 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs5493280761e-14RNU6-896P - HMGB3P19G2.2
rs1507084952e-14LINC01320C3.49
rs5692869683e-13PREX2C2.28
rs5384486367e-12CAMK2DA1.98
rs348022622e-08JAZF1?

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90479202Verma A20244,302445,275Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90436821Zhou W20181,692387,765Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.
GCST90044639Jiang L20211,662454,686A generalized linear mixed model association tool for biobank-scale data.
GCST90651536Liu TY20251,209210,203Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population.
GCST90479201Verma A2024621120,961Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90480599Verma A2024621120,961Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90482514Verma A202442259,283Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding0
Tier 2: splice/UTR0
Tier 3: regulatory0
Tier 4: intronic/intergenic5

MAF distribution

BucketVariants
common (>=0.05)1
low_freq (0.01-0.05)0
rare (<0.01)4
unknown0

Functional consequences

ConsequenceCount
intron_variant3
intergenic_variant2

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs5493280766153928708G>A0.002intergenic_variantRNU6-896P - HMGB3P191e-14Tier 4: intronic/intergenic
rs150708495234559000C>T0intergenic_variantLINC013202e-14Tier 4: intronic/intergenic
rs569286968868001857C>T0intron_variantPREX23e-13Tier 4: intronic/intergenic
rs5384486364113504938A>G0.001intron_variantCAMK2D7e-12Tier 4: intronic/intergenic
rs34802262727874966GA>G0.05intron_variantJAZF12e-08Tier 4: intronic/intergenic

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated for this disease

No approved or late-stage (phase ≥3) drug is indicated for this disease; the following are in earlier-phase trials only.

Earlier-phase candidates (phase 2, investigational — efficacy not yet established): Lidocaine, Triamcinolone Acetonide.

Clinical trials & evidence

Clinical trials

Clinical trials: 55.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified48
PHASE42
PHASE32
PHASE21
EARLY_PHASE11
PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT03796572PHASE4RECRUITINGRegional Blocks for Lateral Condyle Fractures
NCT01105832PHASE4COMPLETEDDoes Teriparatide (rhPTH 1-34) Promote Fracture Healing in Proximal Humeral Fractures?
NCT02091492PHASE3WITHDRAWNTeriparatide for Fracture Repair in Humans
NCT02418260PHASE3UNKNOWNSurgical Interventions for the Treatment of Humeral Shaft Fractures
NCT04216017PHASE2COMPLETEDGlenohumeral Cortisone Injection
NCT02733666PHASE1COMPLETEDInternal Fixation of Lateral Humeral Condyle Fractures With Absorbable Screws in Children
NCT02467803EARLY_PHASE1UNKNOWNShoulder Functional Outcomes of Patients With Proximal Humerus Fractures: Comparison of Two Different Treatment Protocol
NCT04640727Not specifiedENROLLING_BY_INVITATIONORIF Versus CRIF of Completely Displaced and Rotated Lateral Condylar Fractures of the Humerus in Children
NCT05019664Not specifiedACTIVE_NOT_RECRUITINGAffixus Natural Nail System Humeral Nail PMCF
NCT05256849Not specifiedACTIVE_NOT_RECRUITINGTreatment of Humeral Fractures With Long PHILOS Plates Using a Modified Technique and Approach Avoids Radial Nerve Palsy
NCT05314387Not specifiedNOT_YET_RECRUITINGS-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem
NCT05668182Not specifiedRECRUITINGA Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects
NCT05868148Not specifiedACTIVE_NOT_RECRUITINGShoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study
NCT06113614Not specifiedRECRUITINGEffects of Photobiomodulation on Functional Recovery of Proximal Humerus Fractures
NCT06869343Not specifiedRECRUITINGEarly Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
NCT07212036Not specifiedRECRUITINGThe Utilization of Ultrasound to Diagnose Pediatric Elbow Fractures
NCT07558941Not specifiedNOT_YET_RECRUITINGConservative Versus Surgical Treatment of Gartland Type II Supracondylar Humeral Fractures in Children - Which One ?
NCT07569575Not specifiedNOT_YET_RECRUITINGMagnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures
NCT00240396Not specifiedWITHDRAWNBimodal Analgesia as Form of Pain Control Post Long Bone Fracture
NCT00358787Not specifiedCOMPLETEDManagement of Displaced Supracondylar Fractures of the Humerus Using Lateral vs. Crossed K-wires
NCT00698750Not specifiedTERMINATEDA Clinical Investigation of the Copeland™ Humeral Resurfacing Head
NCT00698867Not specifiedCOMPLETEDA Clinical Investigation of the Discovery™ Elbow System
NCT00699270Not specifiedWITHDRAWNA Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems
NCT00720681Not specifiedCOMPLETEDPlating of Humeral Shaft Fractures in Multiple Trauma Patients.
NCT00772850Not specifiedCOMPLETEDRotator Cuff Injury in Antegrade Locked Nailing for Humeral Fractures
NCT00793637Not specifiedCOMPLETEDEvaluation of Handling and Possible Complications Related to the Newly Developed Angular Stable Locking System (ASLS)
NCT00999193Not specifiedTERMINATEDProximal Humeral Comminuted Fractures in the Elderly - PERCELE Trial
NCT01017289Not specifiedUNKNOWNIntramedullary Fixation of Humerus Fractures
NCT01051869Not specifiedCOMPLETEDSimple Decompression Versus Anterior Transposition of the Ulnar Nerve
NCT01087463Not specifiedUNKNOWNIntramedullary Fixation of Humerus Fractures Without Intramedullary Reaming
NCT01524965Not specifiedTERMINATEDThe Effect of the Timing of Postoperative Mobilisation After Locking Plate Osteosynthesis of Fractures of the Surgical Neck of the Humerus
NCT01812863Not specifiedWITHDRAWNPain Management in Children Undergoing Supracondylar Humerus Fracture Repair
NCT01847508Not specifiedCOMPLETEDPHILOS Augmented - a Multicenter Randomized Controlled Trial
NCT01877434Not specifiedCOMPLETEDReversed TESS Shoulder Artroplasty
NCT01984112Not specifiedCOMPLETEDProximal Humerus Fractures: Randomized Study Between Locking Nails and Locking Plates for Neer 2 and 3 Parts
NCT02170545Not specifiedCOMPLETEDCT Imaging Evaluation of Humerus Fractures
NCT02566018Not specifiedCOMPLETEDTreatment of Proximal Humerus Fractures in the Elderly
NCT02640027Not specifiedCOMPLETEDThe Use of Telemedicine Tool in Supracondylar Humerus Fractures in Children
NCT02750839Not specifiedUNKNOWNInfluence of Osteoporosis on Clinical Outcomes of Mini-invasive Surgical Treatment of Proximal Humerus Fractures
NCT02756156Not specifiedUNKNOWNLow Dose Interscalene and Infraclavicular Block for Humerus Surgery

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
TERIPARATIDE42